News focused on: Jane H Buckner, MD; Lab Buckner
External News
Science in Seattle: IL-6–targeted therapies to block the cytokine or its receptor drive distinct alterations in T cell function
Read the Publication ➡
News
New Type 1 Diabetes Research Breakthrough: Development of Engineered T Cells as Potential Treatment
Read More
External News
Islet-homing engineered T regs protect against Type 1 diabetes
Read more ➡
Press Release
New Type 1 Diabetes Research Breakthrough: Development of Engineered T Cells as Potential Treatment
Read More
External News
Seahawks Rumble on the Ridge tournament kicks off Boeing Classic
Read more ➡
Press Release
Benaroya Research Institute Awarded $11.4M NIH U19 Grant to Profile Respiratory Viral Infections in Vulnerable Populations and $3.9M NIH R01 Grant to Develop New Treatments for Type 1 Diabetes
Read More
External News
Studies on respiratory infections, type 1 diabetes, boosted with $17M to Benaroya Research Institute
Read more ➡
External News
Benaroya Research Institute lands $17.1M in NIH research grants
Read more ➡
Press Release
Soo Jung Yang, PhD, Named Associate Member in the Center for Translational Research at Benaroya Research Institute
Read More
External News
Publication of the Week: Deep Immune Phenotyping Reveals Similarities between Aging, Down Syndrome, and Autoimmunity
Read publication ➡
External News
Publication of the Week: Endomembrane Targeting of Human OAS1 p46 Augments Antiviral Activity
Read publication ➡
External News
Nature Outlook: Creating T cells to guard against autoimmune disease
Read publication ➡Press Release
BRI President Jane Buckner, MD, Elected to FOCiS Leadership
Read More
External News
Science in Seattle: What COVID-19 Is Teaching Us About the Immune System
Read blog ➡
News
